Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | AHR | P35869 | 1/20 | 0.52 |
| ▸ | KIF11 | P52732 | 2/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.50 |
| ▸ | GABRP | O00591 | 1/20 | 0.50 |
| ▸ | GABRD | O14764 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzophenone SCHEMBL27485001 | 0.89 | ALDH1A1 (0.61) | ALDH1A1KDM4EKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL9625537 | 0.89 | KDM4E (0.54) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| SCHEMBL17124538 | 0.86 | ALDH1A1 (0.56) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| SCHEMBL70283 | 0.86 | KDM4E (0.60) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| SCHEMBL29823892 | 0.86 | KDM4E (0.60) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| SCHEMBL25515699 | 0.85 | ALDH1A1 (0.65) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| Hydrochloric Acid SCHEMBL6434116 | 0.84 | KDM4E (0.59) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| SCHEMBL27741500 | 0.84 | KDM4E (0.59) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 | |
| SCHEMBL29152717 | 0.84 | ATM (0.57) | ALDH1A1KDM4EKMT2AMEN1RAB9A | |
| SCHEMBL11063183 | 0.83 | KIF11 (0.62) | ALDH1A1KDM4EKMT2AMEN1HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4483989-A | BENZOYLATION 6-HYDROXYCARBAZOLE, FORMYLATING, CYCLIZATION, AND SAPONIFICATION | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1984-11-20 | — | — | US | claimed |
| US-10364221-B2 | Monomer, organic layer composition, organic layer, and method of forming patterns | SAMSUNG SDI CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2017-01-12 | — | — | US | disclosed |
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10364221-B2 | Monomer, organic layer composition, organic layer, and method of forming patterns | MSMO1, NOM1, CD68 | ALDH1A1 485/4885KDM4E 3936/4885KMT2A 3422/4885 |
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | MSMO1, NOM1, CD68 | ALDH1A1 485/4885KDM4E 3936/4885KMT2A 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.